Sponsors

RECENT NEWS

PerkinElmer introduces ready-to-use viral vector assays for gene therapy

PerkinElmer has launched ready-to-use adeno-associated virus vectors (AAV) detection kits to support researchers working on gene therapies for a variety of serious diseases.

Menarini and QuantuMDx introduce new Q-POC PCR device

QuantuMDx and its exclusive UK distributor Menarini are launching the new Q-POC rapid, point-of-care PCR testing device for SARS-CoV-2.

PCR Biosystems launches next-generation of qPCR reagents

PCR Biosystems has launched a new family of qPCR reagents mixes: Clara Probe Mix, Clara Probe 1-Step Mix and Clara HRM Mix. The cutting-edge Clara family of mixes rely on a novel composition to push the boundaries of performance to meet the challenges of today’s laboratories.

Proscia to showcase improvements in AI generalisation

Proscia, a provider of digital and computational pathology solutions, has announced new research on improving the generalisation of an artificial intelligence (AI) classification model with contrastive self-supervised learning.

Lab Innovations celebrates its tenth anniversary

The Lab Innovations show returned to the NEC, Birmingham, earlier this month to drive sustainability and innovation in laboratories and celebrate its tenth anniversary.

Enalees opens first subsidiary in the UK

Enalees, a company specialising in the design, development, production and marketing of state-of-the-art rapid molecular diagnostic tests, such as LAMP PCR (Loop-mediated isothermal AMPlification Polymerase Chain Reaction), for the veterinary profession, has announced the establishment of its first European subsidiary in North Yorkshire, UK.

New remotely controlled heating stations from Torrey Pines Scientific

Torrey Pines Scientific has launched the new EchoTherm RHB20 series of remotely controlled heating stations for robotic systems, fume hoods and controlled environmental chambers.

Bio-Rad introduces Pioneer Antibody Discovery Platform

Bio-Rad Laboratories has announced the launch of the Pioneer Antibody Discovery Platform, a new antibody discovery service specifically designed to develop best-in-class biologic candidates.

Northern Ireland launches digital health diagnostics programme

NIPACS+ will support the creation of regional networks of care and will help the region to transform diagnostic services, as healthcare professionals benefit from a single point of access to medical images.

Tecan and RevoluGen partner on using 96-well plates for DNA extraction

UK genomics company RevoluGen has announced an agreement with Tecan for the manufacturing and supply of Tecan’s 96-well filter plates to be used in RevoluGen’s automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.

Evident and Ultivue collaborate to advance multiplex slide imaging

Life science imaging systems manufacturer Evident Corporation and Ultivue, an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, have announced a collaborative agreement to promote whole slide imaging using multiplexed immunofluorescence (mIF) assays to advance translational research in the Americas.

EnteroBiotix partners with Imperial College London for microbiome therapeutics

EnteroBiotix, a full-spectrum microbiome therapeutics company, has announced a partnership with Imperial College London to develop microbiome R&D in patients suffering from blood cancer as well as accelerate systematic research in the new science of the microbiome.

BIOHIT HealthCare is exhibiting at the BSI Congress 2022

BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.

qLabs FIB - a new POC device from Stago

Diagnostica Stago is launching qLabs FIB - a novel POC device which measures fibrinogen levels from a single drop of whole blood, further expanding the company’s near-patient testing solutions for the critical care setting.

West Midlands Cancer Alliance goes digital with Sectra

NHS patients throughout the West Midlands are to benefit from a digital pathology programme, designed to help reduce cancer backlogs, transform services, and improve the speed and accuracy of cancer diagnosis.

Clinical trial sees patients receive laboratory grown red blood cells

Red blood cells that have been grown in a laboratory have now been transfused into another person in a world first clinical trial. The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers in the RESTORE randomised controlled clinical trial.

SYNLAB investing £2.4 million in major modernisation programme

A £2.4 million investment in state-of-the-art pathology automation solutions is helping to deliver improved care for millions of patients across the UK. SYNLAB has installed world-leading laboratory equipment at three of its NHS partnerships, which combined serve more than four million people.

TissueCypher Barrett’s Esophagus Test can improve outcomes for patients with low-grade dysplasia

Castle Biosciences has announced new data showing that the use of TissueCypher Barrett’s Esophagus Test results can significantly improve management decisions for Barrett’s oesophagus (BE) patients with low-grade dysplasia (LGD) to improve health outcomes.

HORIBA to host feline infectious peritonitis CPD webinar

Feline veterinary specialist Dr Samantha Taylor will be discussing the complexities of feline infectious peritonitis (FIP) at HORIBA’s latest free-to-attend online CPD webinar.

SYNLAB and Microba reinforce myBIOME collaboration

SYNLAB and Microba Life Sciences have expanded their strategic agreement to broaden geographic and market availability of the microbiome test myBIOME across Europe and Latin America.

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025